Related Experiment Video
Updated: Sep 26, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
[The return of thalidomide]
1Ospedale San Filippo Neri, Roma.
Abstract:
Nearly four decades after its withdrawal from the marketplace because of the discover of its teratogenicity, the thalidomide is now attracting a renewed interest due to the identification of its important anti-inflammatory, immunomodulatory and anti-angiogenic effects. After the approval in the United States of the thalidomide for treatment of erythema nodosum leprosum, several studies have been conducted in patients with dermatologic disorders, conditions associated with HIV infection, graft-versus-host disease, rheumatoid arthritis, Cron's disease, and cancer. In this paper the mechanisms of action of thalidomide and its indications in human diseases are summarized.
More Related Videos
Related Concept Videos
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Teratogenicity
Desensitization and Tachyphylaxis
Several...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

